Dr Luis Zapata Ortiz leads a dedicated research group focusing on advancing our understanding of the immune system's role in genetic variability and its implications for disease, cancer and ageing.

Researchers have uncovered new details about the complex relationship between the immune system and cancer. They have shown that this relationship can influence the distribution and frequency of ...

I woke up on 29 July, 2020 with a severe pain in my right side, around where my gallbladder is. I tried to go back to sleep, deciding that if the pain was still there in the morning, I would call for ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Professor Trevor Graham's group harnesses artificial intelligence and the principles of evolution with the aim of improving cancer prevention, diagnosis and treatment. Trevor Graham is Professor of ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk ...

"Search" is our twice-yearly newsletter to supporters. In our 50th edition of the Autumn Search issue, we look at the latest research news featuring a new breast cancer drug approval in the UK, for ...